Atlas Trials

CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy

Clinical trial NCT02654977 · COMPLETED

Trial details

NCT number
NCT02654977
Sponsor
University of Michigan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Familial Partial LipodystrophyNonalcoholic SteatohepatitisNAFLD
Start date
2015-09-29
Primary completion
2019-11-14
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.